These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16875721)

  • 1. The pattern of Protease Activated Receptor 1 (PAR1) expression in endometrial carcinoma.
    Granovsky-Grisaru S; Zaidoun S; Grisaru D; Yekel Y; Prus D; Beller U; Bar-Shavit R
    Gynecol Oncol; 2006 Dec; 103(3):802-6. PubMed ID: 16875721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples.
    Grisaru-Granovsky S; Salah Z; Maoz M; Pruss D; Beller U; Bar-Shavit R
    Int J Cancer; 2005 Jan; 113(3):372-8. PubMed ID: 15455382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma.
    Planagumà J; Abal M; Gil-Moreno A; Díaz-Fuertes M; Monge M; García A; Baró T; Xercavins J; Reventós J; Alameda F
    J Pathol; 2005 Dec; 207(4):422-9. PubMed ID: 16175655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1.
    Briese J; Schulte HM; Bamberger CM; Löning T; Bamberger AM
    Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
    Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
    Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Smad4 protein expression occurs infrequently in endometrial carcinomas.
    Liu FS; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
    Int J Gynecol Pathol; 2003 Oct; 22(4):347-52. PubMed ID: 14501814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
    Onuma K; Dabbs DJ; Bhargava R
    Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of human protease-activated receptor 1: a role for the early growth response-1 protein in prostate cancer.
    Salah Z; Maoz M; Pizov G; Bar-Shavit R
    Cancer Res; 2007 Oct; 67(20):9835-43. PubMed ID: 17942914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin 19 expression in normal endometrium and in low-grade endometrioid adenocarcinoma of the endometrium.
    Stewart CJ; Crook ML; Lacey J; Louwen K
    Int J Gynecol Pathol; 2011 Sep; 30(5):484-91. PubMed ID: 21804393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
    Pilka R; Norata GD; Domanski H; Andersson C; Hansson S; Eriksson P; Casslén B
    Gynecol Oncol; 2004 Sep; 94(3):661-70. PubMed ID: 15350356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
    Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
    J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer.
    Bamberger AM; Riethdorf L; Nollau P; Naumann M; Erdmann I; Götze J; Brümmer J; Schulte HM; Wagener C; Löning T
    Am J Pathol; 1998 Jun; 152(6):1401-6. PubMed ID: 9626043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haptoglobin expression in endometrioid adenocarcinoma of the uterus.
    Nabli H; Tuller E; Sharpe-Timms KL
    Reprod Sci; 2010 Jan; 17(1):47-55. PubMed ID: 19801537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G; Gnetti L; Merisio C; Melpignano M
    Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
    Soufla G; Sifakis S; Spandidos DA
    Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease activated receptor-1, PAR1, promotes placenta trophoblast invasion and beta-catenin stabilization.
    Grisaru-Granovsky S; Maoz M; Barzilay O; Yin YJ; Prus D; Bar-Shavit R
    J Cell Physiol; 2009 Mar; 218(3):512-21. PubMed ID: 19040205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of receptor-binding cancer antigen expressed on SiSo cells in endometrial carcinoma and the correlation thereof with the expression of estrogen receptor subtypes].
    Zhou XH; Xu ST; Song WY; Teng XD
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1900-3. PubMed ID: 17923013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
    Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
    Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
    Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
    Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.